Kirsten I. Taylor - University of Cambridge

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 155 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Exploratory Digital Outcome Measures of Motor Sign Progression in Parkinson's Disease Patients Treated with Prasinezumab

Kirsten I Taylor,Florian Lipsmeier, Marzia A Scelsi, Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht, Judith Anzures-Cabrera, David Summers,Markus Abt,Annabelle Monnet, Timothy Kilchenmann, Jens Schjodt-Eriksen,Laurent Essioux, Thomas Kustermann,Wagner Zago,Hanno Svoboda, Tania Nikolcheva,Ronald B Postuma,Gennaro Pagano,Michael Lindemann, PASADENA Investigators, Prasinezumab Study Group

NPJ digital medicineno. 1 (2025): 365-365

Cited0Views0WOSBibtex

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease (PD) (PADOVA): Rationale, Design, and Baseline Data

T. Nikolcheva,G. Pagano,N. Pross,T. Simuni,K. Marek,R. Postuma,N. Pavese,F. Stocchi, K. Seppi, G. Respondek,A. Monnet,N. Shariati,L. Rutten-Jacobs,T. Kustermann,K. Taylor,D. Trundell,H. Svoboda,A. Bonni,P. Fontoura,R. Doody

MOVEMENT DISORDERS (2024): S345-S345

Cited0Views0Bibtex

Exploratory Sensor-based Outcome Measures Show Divergent Slopes of Motor Sign Progression in Parkinson’s Disease Patients Treated with Prasinezumab

Kirsten Taylor,Florian Lipsmeier, Marzia Scelsi,Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht,Judith Anzures-Cabrera, David Summers,Markus Abt,Annabelle Monnet,Timothy Kilchenmann,Jens Schjodt-Eriksen,Laurent Essioux,Thomas Kustermann,Wagner Zago,Hanno Svoboda,Tania Nikolcheva,Ronald Postuma,Gennaro Pagano,Michael Lindemann

crossref（2024）

Cited1Views0Bibtex

Digital Health Technology (DHT) Derived Features As Sensitive Measures of Disease Progression in Early Parkinson's Disease (PD) under Stable Dopaminergic Treatment

F. Lipsmeier, S. Lambrecht, S. Fraessle, Y. Gazizova, D. Kwasny, P. Wacht, B. Fehlmann,T. Kustermann,M. Lindemann,W. Popp,K. Taylor,R. Postuma

MOVEMENT DISORDERS（2024）

Cited0Views0Bibtex

PASADENA 1-Year Open-label Extension

G. Pagano, A. Reyes,A. Monnet,M. Martinec,N. Shariati,T. Simuni,K. Marek,R. Postuma,N. Pavese,F. Stocchi,K. Taylor,H. Svoboda,P. Fontoura,G. Kerchner,R. Doody,A. Bonni,T. Nikolcheva

MOVEMENT DISORDERS (2023): S44-S44

Cited0Views0Bibtex

The Neuro Genomics Partnership: A New Consortium Dedicated to a Fully Open Patient to Patient (P2P) Integrative R&D Approach

Clotilde Degroot,Kirsten Taylor,Vincent Mooser,Guy Rouleau,Ziv Gan-Or,Madeleine Sharp,Thomas Durcan,Ronald Postuma,Julien Doyon,Thomas Kustermann,Ravi Jagasia, Caitlin Taylor,Marc Lussier,Edward Fon

Journal of the Neurological Sciences（2023）

Cited0Views0Bibtex

Functional Neuroanatomic Validity of a Novel, Smartphone‐based Remote Assessment of Processing Speed in Early Alzheimer’s Disease

Kirsten I Taylor, Irma T Kurniawan,Arnaud M Wolfer,Florian Lipsmeier,Thanneer M Perumal

Alzheimer's &amp Dementiano. S18 (2023)

Cited0Views0Bibtex

Exploratory Delayed-Start Analysis of PASADENA Part 3 52-Week OLE Evaluating Prasinezumab Efficacy on Motor Progression and Complications in Early-Stage PD (S32.005)

Gennaro Pagano,Stefano Zanigni,Annabelle Monnet,Kirsten Taylor,Andrea Hahn,Tanya Simuni,Kenneth Marek,Ronald Postuma,Nicola Pavese,Fabrizio Stocchi,Hanno Svoboda,Paulo Fontoura,Rachelle Doody,Geoffrey Kerchner,Azad Bonni,Tania Nikolcheva

Neurologyno. 17_supplement_2 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn